Viewing Study NCT01781702


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2025-12-26 @ 2:36 AM
Study NCT ID: NCT01781702
Status: COMPLETED
Last Update Posted: 2013-08-09
First Post: 2013-01-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients
Sponsor: Daewon Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module Annotation Module